Octagon Capital Group
Overview
Octagon Capital Group is a merchant banking firm that combines top-tier investment banking capabilities with an intense focus on funding, building up and monetizing high potential companies . They focus primarily on small-cap, mid-cap and private companies with significant potential for value-creation, working closely with senior management teams, owners, and boards . The firm has deep experience across sectors, situations and transaction types, from tactical and transformational M&A, to growth capital, to distressed situations requiring complex solutions to maximize value .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EpimAb Biotherapeutics | Mar 2021 | Series C | - |
| Undercover Snacks | Jul 2021 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Octagon Capital Group based?
Octagon Capital Group is headquartered in New York City, New York, United States.
When was Octagon Capital Group founded?
Octagon Capital Group was founded in 2014.
How many portfolio companies does Octagon Capital Group have?
Octagon Capital Group has 2 portfolio companies in Caplight's dataset.
What are some companies in Octagon Capital Group's portfolio?
Portfolio companies visible on Caplight include EpimAb Biotherapeutics, Undercover Snacks.
What was Octagon Capital Group's most recent investment shown here?
Octagon Capital Group's most recent investment in this portfolio sample was in Undercover Snacks in 2021.
What sectors does Octagon Capital Group focus on?
Octagon Capital Group focuses on Consumer & Commerce, Healthcare & Life Sciences.
What company stages does Octagon Capital Group focus on?
Octagon Capital Group typically invests at the Mid stage.
What is Octagon Capital Group's AUM?
Octagon Capital Group's assets under management are estimated between $500.0M and $1.0B.